Lunai Bioworks Operating Income 2013-2025 | LNAI
Lunai Bioworks operating income from 2013 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Lunai Bioworks Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $-189 |
| 2024 | $-82 |
| 2023 | $-39 |
| 2022 | $-116 |
| 2021 | $-23 |
| 2020 | $-12 |
| 2019 | $-11 |
| 2018 | $-5 |
| 2017 | $-2 |
| 2016 | $-2 |
| 2015 | |
| 2014 | $-2 |
| 2014 | $-2 |
| 2013 | $-2 |
| 2013 | $-2 |
|
Lunai Bioworks Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-127 |
| 2025-03-31 | $-4 |
| 2024-12-31 | $-5 |
| 2024-09-30 | $-53 |
| 2024-06-30 | $-17 |
| 2024-03-31 | $-51 |
| 2023-12-31 | $-4 |
| 2023-09-30 | $-9 |
| 2023-06-30 | $-23 |
| 2023-03-31 | $-4 |
| 2022-12-31 | $-4 |
| 2022-09-30 | $-7 |
| 2022-06-30 | $-98 |
| 2022-03-31 | $-4 |
| 2021-12-31 | $-6 |
| 2021-09-30 | $-8 |
| 2021-06-30 | $-14 |
| 2021-03-31 | $-3 |
| 2020-12-31 | $-3 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-3 |
| 2020-03-31 | $-4 |
| 2019-12-31 | $-3 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $-3 |
| 2018-12-31 | $-4 |
| 2018-09-30 | $-2 |
| 2018-06-30 | $0 |
| 2018-03-31 | $-3 |
| 2017-12-31 | $-1 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $0 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-1 |
| 2016-06-30 | $-1 |
| 2016-03-31 | $-1 |
| 2015-12-31 | $-1 |
| 2015-09-30 | $0 |
| 2015-03-31 | $-1 |
| 2014-12-31 | |
| 2014-09-30 | $-1 |
| 2014-06-30 | $-1 |
| 2013-12-31 | |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.021B | $0.000B |
| Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.476B | 59.15 |
| Tempus AI (TEM) | United States | $12.470B | 0.00 |
| Doximity (DOCS) | United States | $9.841B | 40.73 |
| Hims & Hers Health (HIMS) | United States | $9.345B | 76.02 |
| IRhythm Technologies (IRTC) | United States | $5.680B | 0.00 |
| Hinge Health (HNGE) | United States | $3.475B | 0.00 |
| Privia Health (PRVA) | United States | $2.879B | 180.08 |
| Heartflow (HTFL) | United States | $2.821B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.501B | 41.38 |
| 10x Genomics (TXG) | United States | $2.126B | 0.00 |
| Enovis (ENOV) | United States | $1.731B | 9.09 |
| Omnicell (OMCL) | United States | $1.652B | 33.77 |
| Azenta (AZTA) | United States | $1.387B | 60.52 |
| Phreesia (PHR) | United States | $1.355B | 0.00 |
| Schrodinger (SDGR) | United States | $1.346B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.333B | 0.00 |
| Claritev (CTEV) | United States | $0.953B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.840B | 0.00 |
| Evolent Health (EVH) | United States | $0.582B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Talkspace (TALK) | United States | $0.560B | 112.67 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Standard BioTools (LAB) | United States | $0.450B | 0.00 |
| Carlsmed (CARL) | United States | $0.335B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.325B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.294B | 0.00 |
| TruBridge (TBRG) | United States | $0.286B | 13.15 |
| CapsoVision (CV) | United States | $0.231B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.210B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.201B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.195B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.183B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.181B | 0.00 |
| CareCloud (CCLD) | United States | $0.143B | 7.84 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Pulmonx (LUNG) | United States | $0.079B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.054B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.000B | 0.00 |